Literature DB >> 23499652

Assessing anxiety in C57BL/6J mice: a pharmacological characterization of the zero maze test.

Luis Heredia1, Margarita Torrente2, María T Colomina1, José L Domingo3.   

Abstract

INTRODUCTION: Anxiety disorders affect the quality of life and good health of millions of people over the world. Because clinical trials are expensive and frequently show high rates of placebo responses, animal models have become an important tool for drug discovery and brain research. Zero maze is a commonly used test to assess anxiety-like levels in mice, being the C57BL/6J strain one of the most widely used. However, only few studies have focused on the pharmacological characterization of this strain in the various anxiety tests.
METHODS: In this study, we analyzed the changes in the anxiety-like behaviors of mice exposed to chlordiazepoxide (CLZ), as an anxiolytic drug, at doses of 2.5, 5 and 10mg/kg, picrotoxine (PTX), as an anxiogenic drug, at doses of 0.5, 1 and 2mg/kg, and methylphenidate (MPH), as a psychomotor stimulant, at doses of 2.5, 5 and 10mg/kg. Data were hand recorded in situ by an observer and through a camcorder by computer software.
RESULTS: Results showed that CLZ and MPH had an anxiogenic effect at the two highest doses. Only CLZ at 2.5mg/kg reduced the anxiety-like levels of mice. Moreover, PTX exerted an anxiogenic effect in mice only at 2mg/kg. The drugs affecting the anxiety-like levels also affected the activity levels. Thus, the differences might have been mediated by changes in activity levels. DISCUSSION: Globally, these data demonstrate that the results obtained from the zero maze test are difficult to interpret when the C57BL/6J strain is used. On the other hand, high doses of substances that interact with the GABAergic system, as CLZ, can produce sedation in these mice. In contrast, high doses of GABAA antagonists, as PTX, are necessary if anxiogenic effects should be observed. Further investigations with this strain are necessary in order to corroborate the results of the present study.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety; C57BL/6J mice; Chlordiazepoxide; Methylphenidate; Picrotoxine; Zero maze test

Mesh:

Substances:

Year:  2013        PMID: 23499652     DOI: 10.1016/j.vascn.2013.02.010

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  3 in total

1.  Dopamine and norepinephrine receptors participate in methylphenidate enhancement of in vivo hippocampal synaptic plasticity.

Authors:  Daniel Jenson; Kechun Yang; Alexandra Acevedo-Rodriguez; Amber Levine; John I Broussard; Jianrong Tang; John A Dani
Journal:  Neuropharmacology       Date:  2014-11-11       Impact factor: 5.250

2.  Methylphenidate Dose-Dependently Affects Aggression and Improves Fear Extinction and Anxiety in BALB/cJ Mice.

Authors:  Amanda Jager; Doranda Kanters; Femke Geers; Jan K Buitelaar; Tamas Kozicz; Jeffrey C Glennon
Journal:  Front Psychiatry       Date:  2019-10-25       Impact factor: 4.157

Review 3.  Preclinical animal anxiety research - flaws and prejudices.

Authors:  Abdelkader Ennaceur; Paul L Chazot
Journal:  Pharmacol Res Perspect       Date:  2016-03-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.